3. STEM CELL CLINICAL TRIAL TO REDUCE SEVERITY OF SYMPTOMS:In collaboration with colleagues at St Vincent’s Hospital Sydney and two Hospitals in Victoria, the Institute aims to conduct a clinical trial of a certain type of stem cell to dampen down the hyper-activity of the immune system that causes severe heart and lung problems in patients with COVID-19. Pending approval, patients with the virus will be injected with a particular stem cell, previously used in patients, to successfully dampen down the immune response that causes problems in other diseases. Specialists are optimistic the cells will do the same for patients with COVID-19-, which is characterised by a significant activation of the immune system.
“Evidence based practice is essential in healthcare but even more crucial in our fight against this pandemic. We know COVID impacts the heart, and in a significant proportion of those who die from the virus they die from heart failure, rhythm problems, and other cardiac complications.Furthermore, those with pre-existing heart conditions are at significant risk if they contract the disease. The Institute has a job to do, and we need to start now,” said Professor Kovacic.
“The spotlight is on science, and never before have the public appreciated how vital medical research is to the health of our community. And as always both government and philanthropic support will be crucial to helping the Institute achieve these projects.”
In a frank disclosure, Professor Kovacic added, “we don’t have specific funding for these projects yet, with so many people out of work and the economic downturn, donations to support our work at the Victor Chang Cardiac Research Institute are going to inevitably diminish. For those who still have work and would like to help, I would encourage you to please be generous. We need your support and we need it in spades.”
Scientists are calling on heart patients who have tested positive to COVID-19 to contact the Institute to participate in their Australian first research.
https://www.victorchang.edu.au/news/australian-scientists-at-heart-of-coronavirus-research
Mesoblast(?) Australian Covid-19 Trial Victor Chang Cardiac Research Institute, page-65
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99680 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |